Skip to content
Search

Latest Stories

Sajid javid thanks pharmacies for delivering over 20 million Covid jabs

Health secretary Sajid Javid visited Medicine Chest Pharmacy in London on Friday (January 28) and thanked pharmacy teams across England for delivering well over 20 million Covid-19 jabs.

According to the latest research conducted by the National Pharmacy Association (NPA) and PharmData, independent community pharmacies were the biggest deliverers of Covid-19 vaccines during January 2021 to September 2021 as compared to corporate-run pharmacy sites.


As of January 2022, pharmacies across the whole sector had delivered 22 million Covid jabs, with the majority of them being independents of whom most are NPA members.

2new Sajid Javid standing outside Medicine Chest pharmacy in London.

In a video message released after the visit, Javid said: “Today I am here at Medicine Chest pharmacy in London to thank them, all pharmacies, the NHS, for the fantastic job they have done particularly over the last few months to get our country boosted. It’s because of this phenomenal success that today we are able to return to Plan A as we see Omicron in retreat and we learn to live with Covid.”

He said that after the success of vaccination programme “we’re able to announce a significant easing of restrictions on care homes” from Monday (January 31), and “will be significantly cutting self-isolation periods.”

Encouraging people to get vaccinated, he added, “please do come forward, get vaccinated, protect yourself and protect your community.”

NPA member Rohit Kotecha who runs Medicine Chest Pharmacy said: “We started Covid jabs in June 2021 and have vaccinated over 22,000 patients. We are open seven days a week and were vaccinating over Christmas and New Year to support the campaign to boost everyone this winter.

“It was good to have the health secretary visit to thank us for our work – it’s really important that politicians get a sense of what we do first hand.”

On decision to deliver Covid jabs, Andrew Hodgson, owner of Andrews Pharmacy in Macclesfield, said he always wanted to take on new services available for pharmacy “as services are the key to the future”.

Andrews Pharmacy is one of the first few community pharmacies to administer Covid-19 vaccines.

“We have a number of consultations rooms so we could get up and running at scale in a relatively short time.

“It was great for the nation and the world but it was good for the pharmacy too.”

Another NPA member, Olivier Picard, who runs the Newdays Pharmacy group, established the Marlow Covid-19 vaccination clinic in a block of offices in Marlow, Buckinghamshire.

Picard with his team and volunteers started administering Covid-19 vaccines from January 22, 2021.

He said: “The reason we wanted to do it was because we were in complete lockdown and we had already been participating in the provision of vaccination for flu and we thought we could do this.”

“This would be the way out of the pandemic and now we are seeing it’s having great benefits on the health of the local population.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less